UNIVERSITATEA DE STAT DE MEDICINA SI FARMACIE NICOLAE TESTEMITANU DIN REPUBLICA MOLDOVA

Their core work

Nicolae Testemitanu State University of Medicine and Pharmacy is Moldova's main medical and pharmaceutical higher education institution, based in Chisinau. In EU research, they contribute Eastern European clinical and public health perspectives to large cross-national consortia — particularly in mental health service delivery and population-level health data. Their value to European projects lies in access to Moldova's distinct healthcare context: a post-Soviet transition country with specific epidemiological patterns and healthcare infrastructure challenges that differ meaningfully from Western European baselines. With only two H2020 participations, their EU research footprint is small, but both projects place them inside large, well-funded networks spanning 30+ countries.

What they specialise in

How they've shifted over time

Their first H2020 project (RECOVER-E, 2018) was grounded in clinical service delivery — specifically deinstitutionalisation and community mental health implementation, a policy challenge highly relevant to post-Soviet health systems. By 2020, their second project (PHIRI) shifted entirely toward data infrastructure, population health metrics, and COVID-19 surveillance, reflecting a move from care delivery toward health informatics and comparative epidemiology. With only two projects it is difficult to call this a firm trend, but the direction — from clinical practice toward health data systems — is consistent with where EU public health research funding has moved post-2020.

They appear to be moving toward health data infrastructure and population-level research, which aligns with EHDS (European Health Data Space) directions — making them a plausible partner for future health data governance or cross-border epidemiology projects.

How they like to work

They have participated exclusively as a consortium partner, never as coordinator, across both H2020 projects. Both projects are large-scale RIA or CSA instruments with broad, multi-country consortia — the 50 unique partners and 32 countries reflect the scale of those networks, not a dense bilateral relationship web built by the university itself. This suggests they join large thematic networks as a national node rather than driving research agendas, which means they are relatively easy to bring into a consortium but unlikely to lead one.

Their 50 partners across 32 countries comes entirely from two large EU consortia, so this reflects network breadth inherited from those projects rather than independently cultivated relationships. Their geographic footprint spans most of the EU plus associated countries, with Moldova giving them a distinct non-EU Eastern European angle.

What sets them apart

They are the only Moldovan medical university with documented H2020 participation, which gives them a rare geographic position for projects requiring data or clinical perspectives from non-EU Eastern Europe. Moldova's healthcare system — underfunded, post-Soviet, with high rates of specific chronic and infectious diseases — provides a contrast case that strengthens cross-national comparisons in population health and mental health research. For consortium builders who need geographic diversity beyond EU-28 borders, this university fills a gap that few other institutions can.

Highlights from their portfolio

• RECOVER-E
  The larger of their two projects (EUR 9,845 EC contribution), focused on real-world implementation of community mental health care across multiple countries — a topic directly relevant to health system reform in transition economies.
• PHIRI
  A COVID-19-era population health infrastructure project linking national health data across 30+ countries, notable for its data governance and metadata standardisation scope, which placed the university inside a major European health data network.